The farnesoid X receptor: a novel drug target?

Author： Claudel Thierry   Sturm Ekkehard   Kuipers Folkert   Staels Bart  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.9, 2004-09, pp. : 1135-1148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 24, Iss. 11, 2017-05 ,pp. : 1147-1157

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Farnesoid X Receptor Target Gene Induction in Human Hepatocytes: Amino Acid Conjugation

By  

Drug Metabolism Letters, Vol. 11, Iss. 2, 2018-02 ,pp. : 138-143

Bentham Science Publishers

Access to resources Recommend Favorite

Hologram QSAR Studies on Farnesoid X Receptor Activators

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 261-267

Bentham Science Publishers

Access to resources Recommend Favorite

The Orphanin FQ / Nociceptin Receptor as a Novel Drug Target in Psychiatric Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 219-224

Bentham Science Publishers

Access to resources Recommend Favorite

Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment

By  

Current Cancer Drug Targets, Vol. 6, Iss. 3, 2006-05 ,pp. : 229-244

Bentham Science Publishers

Access to resources Recommend Favorite